Tony Sycamore, Market Analyst, IG shares his technical views on the Nasdaq, ASX200, gold and crude oil
Analysts forecast solid earnings growth for all divisions of COG Financial Services over FY26-27
It’s been a long road for medical device manufacturer ImpediMed, but analysts believe the company is now ready to increase scale
An exhaustion of sellers with a break out through previous resistance should pave the way for Macquarie shares to recover, Fairmont Equities’ Michael Gable reports
The new Rio Tinto CEO’s updated targets for earnings, volumes, costs and capex have been met with mixed responses from analysts
Overviews in raw numbers and calculations that might assist investors with assessing trends and currents that might not be apparent from daily volatility and movements
The collapse of Shield and First Guardian Master Funds has triggered one of ASIC’s largest investigations, marking a definitive shift in enforcement strategy that targets the entire financial product supply chain
Imdex has continued to pay up for strategic acquisitions with the latest offerings serving up growth opportunities across products, software and geographic regions
Yet another guidance downgrade from Bapcor brings management’s expectation of a second half turnaround into question
NextDC’s contract utilisation and capex update highlights potential to far exceed FY25 numbers
